UK markets close in 25 minutes

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
48.71+2.74 (+5.96%)
As of 11:04AM EST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
91,952
51,844
24
18
Operating expenses
Research development
322,034
387,087
103,179
54,619
Selling general and administrative
82,896
57,222
29,605
20,553
Total operating expenses
404,930
444,309
132,784
75,172
Operating income or loss
-312,978
-392,465
-132,760
-75,154
Interest expense
-
-
-
187
Total other income/expenses net
-7,798
21,836
-63,400
-5,471
Income before tax
-313,036
-370,638
-194,592
-78,326
Income from continuing operations
-315,446
-370,638
-194,592
-78,326
Net income
-315,446
-370,638
-194,592
-78,326
Net income available to common shareholders
-315,446
-370,638
-195,869
-91,040
Basic EPS
-
-5.77
-4.19
-2.01
Diluted EPS
-
-5.77
-4.19
-2.01
Basic average shares
-
64,228
46,733
45,325
Diluted average shares
-
64,228
46,733
45,325
EBITDA
-
-385,014
-128,025
-74,636